Is LAVA Therapeutics NV (LVTX) Stock at the Top of the Biotechnology Industry?

A rating of 92 puts LAVA Therapeutics NV (LVTX) near the top of the Biotechnology industry according to InvestorsObserver. LAVA Therapeutics NV's score of 92 means it scores higher than 92% of stocks in the industry. LAVA Therapeutics NV also received an overall rating of 78, putting it above 78% of all stocks. Biotechnology is ranked 19 out of the 148 industries.

LVTX has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on LVTX!

See Full LVTX Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With LAVA Therapeutics NV Stock Today?

LAVA Therapeutics NV (LVTX) stock is down -10.49% while the S&P 500 has risen 0.11% as of 1:57 PM on Thursday, Mar 28. LVTX is lower by -$0.41 from the previous closing price of $3.91 on volume of 366,117 shares. Over the past year the S&P 500 has risen 30.45% while LVTX has risen 113.41%. LVTX lost -$1.57 per share the over the last 12 months. Click Here to get the full Stock Report for LAVA Therapeutics NV stock.